Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

Delayed Data
As of Feb 05
 -0.35 / -5.19%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Generic

Company Description

TherapeuticsMD, Inc. is a pharmaceutical company, which focuses on creating and commercializing products targeted exclusively for women. It manufactures and distributes generic prescription prenatal vitamin, as well as over-the-counter and cosmetics. The company is currently focused on conducting the clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy, pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD was founded by Robert G. Finizio in 2008 and is headquartered in Boca Raton, FL.

Contact Information

TherapeuticsMD, Inc.
6800 Broken Sound Parkway NW
Boca Raton Florida 33487
P:(561) 961-1900
Investor Relations:
(561) 961-1930



Mutual fund holders46.27%
Other institutional23.32%
Individual stakeholders23.02%

Top Executives

Robert G. FinizioChief Executive Officer & Director
John C. K. MilliganPresident, Secretary & Director
Daniel Alan CartwrightChief Financial Officer, Treasurer & VP
Brian A. BernickDirector & Chief Clinical Officer
Sebastian MirkinChief Medical Officer